A distinct regulatory sequence is essential for the expression of a subset of nle genes in attaching and effacing Escherichia coli

Journal of Bacteriology

Volumn 194, Issue 20, 2012, Pages 5589-5603

  García Angulo, Víctor A ^a,b   Martínez Santos, Verónica I ^a   Villaseñor, Tomás ^a   Santana, Francisco J ^a   Huerta Saquero, Alejandro ^a   Martínez, Luary C ^a   Jiménez, Rafael ^a   Lara Ochoa, Cristina ^a   Téllez Sosa, Juan ^a,c   Bustamante, Víctor H ^a   Puente, José L ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b INSTITUTO DE BIOTECNOLOGÍA   (Mexico)

^c INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL GENE; CONTROLLED STUDY; ESCHERICHIA COLI; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC CODE; INDEL MUTATION; NONHUMAN; NUCLEOTIDE REPEAT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY SEQUENCE; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ADHESINS, BACTERIAL; CONSERVED SEQUENCE; DNA, BACTERIAL; ENTEROPATHOGENIC ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; GENE EXPRESSION REGULATION, BACTERIAL; INVERTED REPEAT SEQUENCES; MUTAGENESIS, SITE-DIRECTED; PROMOTER REGIONS, GENETIC; SEQUENCE DELETION;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 84868553607     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.00190-12     Document Type: Article

References (100)

1. Abe H, et al. 2008. Global regulation by horizontally transferred regulators establishes the pathogenicity of Escherichia coli. DNA Res. 15: 25-38.
2. Barba J, et al. 2005. A positive regulatory loop controls expression of the locus of enterocyte effacement-encoded regulators Ler and GrlA. J. Bacteriol. 187:7918-7930.
3. Bhatt S, Romeo T, Kalman D. 2011. Honing the message: posttranscriptional and post-translational control in attaching and effacing pathogens. Trends Microbiol. 19:217-224.
4. Bulgin RR, Arbeloa A, Chung JC, Frankel G. 2009. EspT triggers formation of lamellipodia and membrane ruffles through activation of Rac-1 and Cdc42. Cell. Microbiol. 11:217-229.
5. Bustamante VH, Santana FJ, Calva E, Puente JL. 2001. Transcriptional regulation of type III secretion genes in enteropathogenic Escherichia coli: Ler antagonizes H-NS-dependent repression. Mol. Microbiol. 39: 664-678.
6. Bustamante VH, et al. 2011. PerC and GrlA independently regulate Ler expression in enteropathogenic Escherichia coli. Mol. Microbiol. 82:398-415.
7. Campellone KG, Robbins D, Leong JM. 2004. EspFU is a translocated EHEC effector that interacts with Tir and N-WASP and promotes Nckindependent actin assembly. Dev. Cell 7:217-228.
8. Caron E, et al. 2006. Subversion of actin dynamics by EPEC and EHEC. Curr. Opin. Microbiol. 9:40-45.
9. Coombes BK, et al. 2008. Molecular analysis as an aid to assess the public health risk of non-O157 Shiga toxin-producing Escherichia coli strains. Appl. Environ. Microbiol. 74:2153-2160.
10. Creuzburg K, et al. 2011. Evolutionary analysis and distribution of type III effector genes in pathogenic Escherichia coli from human, animal and food sources. Environ. Microbiol. 13:439-452.
11. Creuzburg K, et al. 2005. The Shiga toxin 1-converting bacteriophage BP-4795 encodes an NleA-like type III effector protein. J. Bacteriol. 187: 8494-8498.
12. Creuzburg K, Schmidt H. 2007. Molecular characterization and distribution of genes encoding members of the type III effector nleA family among pathogenic Escherichia coli strains. J. Clin. Microbiol. 45:2498-2507.
13. Dahan S, et al. 2005. EspJ is a prophage-carried type III effector protein of attaching and effacing pathogens that modulates infection dynamics. Infect. Immun. 73:679-686.
14. Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U. S. A. 97:6640-6645.
15. Dean P, Kenny B. 2009. The effector repertoire of enteropathogenic E. coli: ganging up on the host cell. Curr. Opin. Microbiol. 12:101-109.
16. De la Cruz MA, Calva E. 2010. The complexities of porin genetic regulation. J. Mol. Microbiol. Biotechnol. 18:24-36.
17. Deng W, et al. 2010. A comprehensive proteomic analysis of the type III secretome of Citrobacter rodentium. J. Biol. Chem. 285:6790-6800.
18. Deng W, et al. 2004. Dissecting virulence: systematic and functional analyses of a pathogenicity island. Proc. Natl. Acad. Sci. U. S. A. 101: 3597-3602.
19. Deng W, et al. 1 June 2012, posting date. Quantitative proteomic analysis of type III secretome of enteropathogenic Escherichia coli reveals an expanded effector repertoire for attaching/effacing bacterial pathogens. Mol. Cell. Proteomics. doi:10.1074/mcp.M111.013672.
20. Dong T, Schellhorn HE. 2010. Role of RpoS in virulence of pathogens. Infect. Immun. 78:887-897.
21. Echtenkamp F, et al. 2008. Characterization of the NleF effector protein from attaching and effacing bacterial pathogens. FEMS Microbiol. Lett. 281:98-107.
22. Edwards RA, Keller LH, Schifferli DM. 1998. Improved allelic exchange vectors and their use to analyze 987P fimbria gene expression. Gene 207:149-157.
23. Elliott SJ, et al. 2000. The locus of enterocyte effacement (LEE)-encoded regulator controls expression of both LEE- and non-LEE-encoded virulence factors in enteropathogenic and enterohemorrhagic Escherichia coli. Infect. Immun. 68:6115-6126.
24. Fass E, Groisman EA. 2009. Control of Salmonella pathogenicity island-2 gene expression. Curr. Opin. Microbiol. 12:199-204.
25. Friedberg D, Umanski T, Fang Y, Rosenshine I. 1999. Hierarchy in the expression of the locus of enterocyte effacement genes of enteropathogenic Escherichia coli. Mol. Microbiol. 34:941-952.
26. Gao X, et al. 2009. Bacterial effector binding to ribosomal protein s3 subverts NF-κB function. PLoS Pathog. 5:e1000708. doi:10.1371/ journal.ppat.1000708.
27. Garcia-Angulo VA, Deng W, Thomas NA, Finlay BB, Puente JL. 2008. Regulation of expression and secretion of NleH, a new non-locus of enterocyte effacement-encoded effector in Citrobacter rodentium. J. Bacteriol. 190:2388 -2399.
28. Garmendia J, Frankel G. 2005. Operon structure and gene expression of the espJ-tccP locus of enterohaemorrhagic Escherichia coli O157:H7. FEMS Microbiol. Lett. 247:137-145.
29. Garmendia J, Frankel G, Crepin VF. 2005. Enteropathogenic and enterohemorrhagic Escherichia coli infections: translocation, translocation, translocation. Infect. Immun. 73:2573-2585.
30. Gooderham WJ, Hancock RE. 2009. Regulation of virulence and antibiotic resistance by two-component regulatory systems in Pseudomonas aeruginosa. FEMS Microbiol. Rev. 33:279-294.
31. Gruenheid S, et al. 2004. Identification and characterization of NleA, a non-LEE-encoded type III translocated virulence factor of enterohaemorrhagic Escherichia coli O157:H7. Mol. Microbiol. 51:1233-1249.
32. Haack KR, Robinson CL, Miller KJ, Fowlkes JW, Mellies JL. 2003. Interaction of Ler at the LEE5 (tir) operon of enteropathogenic Escherichia coli. Infect. Immun. 71:384-392.
33. Hayward RD, Leong JM, Koronakis V, Campellone KG. 2006. Exploiting pathogenic Escherichia coli to model transmembrane receptor signalling. Nat. Rev. Microbiol. 4:358-370.
34. Hemrajani C, et al. 2010. NleH effectors interact with Bax inhibitor-1 to block apoptosis during enteropathogenic Escherichia coli infection. Proc. Natl. Acad. Sci. U. S. A. 107:3129-3134.
35. Hemrajani C, et al. 2008. Role of NleH, a type III secreted effector from attaching and effacing pathogens, in colonization of the bovine, ovine, and murine gut. Infect. Immun. 76:4804-4813.
36. Holmes A, et al. 2012. Expression and regulation of the Escherichia coli O157:H7 effector proteins NleH1 and NleH2. PLoS One 7:e33408. doi: 10.1371/journal.pone.0033408.
37. Huang LH, Syu WJ. 2008. GrlA of enterohemorrhagic Escherichia coli O157:H7 activates LEE1 by binding to the promoter region. J. Microbiol. Immunol. Infect. 41:9-16.
38. Iguchi A, et al. 2009. Complete genome sequence and comparative genome analysis of enteropathogenic Escherichia coli O127:H6 strain E2348/69. J. Bacteriol. 191:347-354.
39. Islam MS, Bingle LE, Pallen MJ, Busby SJ. 2011. Organization of the LEE1 operon regulatory region of enterohaemorrhagic Escherichia coli O157:H7 and activation by GrlA. Mol. Microbiol. 79:468-483.
40. Ito W, Ishiguro H, Kurosawa Y. 1991. A general method for introducing a series of mutations into cloned DNA using the polymerase chain reaction. Gene 102:67-70.
41. Iyoda S, Watanabe H. 2005. ClpXP protease controls expression of the type III protein secretion system through regulation of RpoS and GrlR levels in enterohemorrhagic Escherichia coli. J. Bacteriol. 187:4086-4094.
42. Jimenez R, Cruz-Migoni SB, Huerta-Saquero A, Bustamante VH, Puente JL. 2010. Molecular characterization of GrlA, a specific positive regulator of ler expression in enteropathogenic Escherichia coli. J. Bacteriol. 192:4627-4642.
43. Jobichen C, et al. 2007. Structure of GrlR and the implication of its EDED motif in mediating the regulation of type III secretion system in EHEC. PLoS Pathog. 3:e69. doi:10.1371/journal.ppat.0030069.
44. Jones BD. 2005. Salmonella invasion gene regulation: a story of environmental awareness. J. Microbiol. 43:110-117.
45. Kaper JB, Nataro JP, Mobley HL. 2004. Pathogenic Escherichia coli. Nat. Rev. Microbiol. 2:123-140.
46. Kelly M, et al. 2006. Essential role of the type III secretion system effector NleB in colonization of mice by Citrobacter rodentium. Infect. Immun. 74:2328-2337.
47. Kendall MM, Gruber CC, Rasko DA, Hughes DT, Sperandio V. 2011. Hfq virulence regulation in enterohemorrhagic Escherichia coli O157:H7 strain 86-24. J. Bacteriol. 193:6843-6851.
48. Kenny B, Abe A, Stein M, Finlay BB. 1997. Enteropathogenic Escherichia coli protein secretion is induced in response to conditions similar to those in the gastrointestinal tract. Infect. Immun. 65:2606-2612.
49. Kim J, et al. 2007. The bacterial virulence factor NleA inhibits cellular protein secretion by disrupting mammalian COPII function. Cell. Host. Microbe 2:160-171.
50. Laaberki MH, Janabi N, Oswald E, Repoila F. 2006. Concert of regulators to switch on LEE expression in enterohemorrhagic Escherichia coli O157:H7: interplay between Ler, GrlA, HNS and RpoS. Int. J. Med. Microbiol. 296:197-210.
51. Lara CA, Huerta-Saquero A, Jimenez-Mejia R, Puente JL. 2009. The repressor activity of GrlR, a LEE-encoded negative regulator of enteropathogenic Escherichia coli, is antagonized by GrlA through proteinprotein interactions, abstr. B-197, p 71. Abstr. 109th Gen. Meet. Am. Soc. Microbiol. American Society for Microbiology, Washington, DC.
52. Lee SF, et al. 2008. A C-terminal class I PDZ binding motif of EspI/NleA modulates the virulence of attaching and effacing Escherichia coli and Citrobacter rodentium. Cell. Microbiol. 10:499-513.
53. Levine MM, et al. 1978. Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are noninvasive. Lancet i:1119-1122.
54. Li M, et al. 2006. Identification and characterization of NleI, a new non-LEE-encoded effector of enteropathogenic Escherichia coli (EPEC). Microbes Infect. 8:2890-2898.
55. Lio JC, Syu WJ. 2004. Identification of a negative regulator for the pathogenicity island of enterohemorrhagic Escherichia coli O157:H7. J. Biomed. Sci. 11:855-863.
56. Marches O, et al. 2008. EspJ of enteropathogenic and enterohaemorrhagic Escherichia coli inhibits opsono-phagocytosis. Cell. Microbiol. 10: 1104-1115.
57. Marches O, et al. 2003. Enteropathogenic and enterohaemorrhagic Escherichia coli deliver a novel effector called Cif, which blocks cell cycle G2/M transition. Mol. Microbiol. 50:1553-1567.
58. Martinez-Laguna Y, Calva E, Puente JL. 1999. Autoactivation and environmental regulation of bfpT expression, the gene coding for the transcriptional activator of bfpA in enteropathogenic Escherichia coli. Mol. Microbiol. 33:153-166.
59. + exchanger regulatory factor 2 (NHERF2) affects trafficking and function of the enteropathogenic Escherichia coli type III secretion system effectors Map, EspI and NleH. Cell. Microbiol. 12:1718-1731.
60. Matsuzawa T, Kuwae A, Abe A. 2005. Enteropathogenic Escherichia coli type III effectors EspG and EspG2 alter epithelial paracellular permeability. Infect. Immun. 73:6283-6289.
61. Mayer MP. 1995. A new set of useful cloning and expression vectors derived from pBlueScript. Gene 163:41-46.
62. Mellies JL, Barron AM, Carmona AM. 2007. Enteropathogenic and enterohemorrhagic Escherichia coli virulence gene regulation. Infect. Immun. 75:4199-4210.
63. Mellies JL, et al. 2011. Ler of Pathogenic Escherichia coli forms toroidal protein-DNA complexes. Microbiology 157:1123-1133.
64. Mellies JL, Elliott SJ, Sperandio V, Donnenberg MS, Kaper JB. 1999. The Per regulon of enteropathogenic Escherichia coli: identification of a regulatory cascade and a novel transcriptional activator, the locus of enterocyte effacement (LEE)-encoded regulator (Ler). Mol. Microbiol. 33:296-306.
65. Mellies JL, Haack KR, Galligan DC. 2007. SOS regulation of the type III secretion system of enteropathogenic Escherichia coli. J. Bacteriol. 189: 2863-2872.
66. Muhlen S, Ruchaud-Sparagano MH, Kenny B. 2011. Proteasomeindependent degradation of canonical NFκB complex components by the NleC protein of pathogenic Escherichia coli. J. Biol. Chem. 286:5100-5107.
67. Mundy R, MacDonald TT, Dougan G, Frankel G, Wiles S. 2005. Citrobacter rodentium of mice and man. Cell. Microbiol. 7:1697-1706.
68. Mundy R, et al. 2004. Identification of a novel Citrobacter rodentium type III secreted protein, EspI, and roles of this and other secreted proteins in infection. Infect. Immun. 72:2288-2302.
69. Nadler C, et al. 2010. The type III secretion effector NleE inhibits NFkappaB activation. PLoS Pathog. 6:e1000743. doi:10.1371/ journal.ppat.1000743.
70. Navarre WW, McClelland M, Libby SJ, Fang FC. 2007. Silencing of xenogeneic DNA by H-NS-facilitation of lateral gene transfer in bacteria by a defense system that recognizes foreign DNA. Genes Dev. 21:1456-1471.
71. Navarre WW, et al. 2006. Selective silencing of foreign DNA with low GC content by the H-NS protein in Salmonella. Science 313:236-238.
72. Newton HJ, et al. 2010. The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-κB p65. PLoS Pathog. 6:e1000898. doi:10.1371/ journal.ppat.1000898.
73. Parker CT, Sperandio V. 2009. Cell-to-cell signalling during pathogenesis. Cell Microbiol. 11:363-369.
74. Petty NK, et al. 2010. The Citrobacter rodentium genome sequence reveals convergent evolution with human pathogenic Escherichia coli. J. Bacteriol. 192:525-538.
75. Pham TH, et al. 2012. Functional differences and interactions between the Escherichia coli type III secretion system effectors NleH1 and NleH2. Infect. Immun. 80:2133-2140.
76. Reading NC, et al. 2007. A novel two-component signaling system that activates transcription of an enterohemorrhagic Escherichia coli effector involved in remodeling of host actin. J. Bacteriol. 189:2468-2476.
77. Roe AJ, et al. 2007. Analysis of the expression, regulation and export of NleA-E in Escherichia coli O157: H7. Microbiology 153:1350-1360.
78. Rojas-Lopez M, et al.2011. Regulatory control of the Escherichia coli O157:H7 lpf1 operon by H-NS and Ler. J. Bacteriol. 193:1622-1632.
79. Royan SV, et al. 2010. Enteropathogenic E. coli non-LEE encoded effectors NleH1 and NleH2 attenuate NF-κB activation. Mol. Microbiol. 78: 1232-1245.
80. Sambrook J, Russell DW. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
81. Sanchez-San Martin C, Bustamante VH, Calva E, Puente JL. 2001. Transcriptional regulation of the orf19 gene and the tir-cesT-eae operon of enteropathogenic Escherichia coli. J. Bacteriol. 183:2823-2833.
82. Schwidder M, Hensel M, Schmidt H. 2011. Regulation of nleA in Shiga toxin-producing Escherichia coli O84:H4 strain 4795/97. J. Bacteriol. 193: 832-841.
83. Shakhnovich EA, Davis BM, Waldor MK. 2009. Hfq negatively regulates type III secretion in EHEC and several other pathogens. Mol. Microbiol. 74:347-363.
84. Sham HP, et al. 2011. Attaching and effacing bacterial effector NleC suppresses epithelial inflammatory responses by inhibiting NF-κB and p38 mitogen-activated protein kinase activation. Infect. Immun. 79: 3552-3562.
85. Shames SR, et al. 2011. The pathogenic Escherichia coli type III secreted protease NleC degrades the host acetyltransferase p300. Cell Microbiol. 13:1542-1557.
86. Shaw RK, et al. 2005. Enteropathogenic Escherichia coli type III effectors EspG and EspG2 disrupt the microtubule network of intestinal epithelial cells. Infect. Immun. 73:4385-4390.
87. Stoebel DM, Free A, Dorman CJ. 2008. Anti-silencing: overcoming H-NS-mediated repression of transcription in Gram-negative enteric bacteria. Microbiology 154:2533-2545.
88. Thanabalasuriar A, et al. 2010. The bacterial virulence factor NleA is required for the disruption of intestinal tight junctions by enteropathogenic Escherichia coli. Cell. Microbiol. 12:31-41.
89. Tobe T, et al. 2006. An extensive repertoire of type III secretion effectors in Escherichia coli O157 and the role of lambdoid phages in their dissemination. Proc. Natl. Acad. Sci. U. S. A. 103:14941-14946.
90. Tree JJ, Wolfson EB, Wang D, Roe AJ, Gally DL. 2009. Controlling injection: regulation of type III secretion in enterohaemorrhagic Escherichia coli. Trends Microbiol. 17:361-370.
91. Umanski T, Rosenshine I, Friedberg D. 2002. Thermoregulated expression of virulence genes in enteropathogenic Escherichia coli. Microbiology 148:2735-2744.
92. Uzzau S, Figueroa-Bossi N, Rubino S, Bossi L. 2001. Epitope tagging of chromosomal genes in Salmonella. Proc. Natl. Acad. Sci. U. S. A. 98: 15264-15269.
93. Vingadassalom D, et al. 2010. Enterohemorrhagic E. coli requires NWASP for efficient type III translocation but not for EspFU-mediated actin pedestal formation. PLoS Pathog. 6:e1001056. doi:10.1371/ journal.ppat.1001056.
94. Vlisidou I, et al. 2006. Identification and characterization of EspK, a type III secreted effector protein of enterohaemorrhagic Escherichia coli O157: H7. FEMS Microbiol. Lett. 263:32- 40.
95. Vossenkamper A, et al. 2010. Inhibition of NF-κB signaling in human dendritic cells by the enteropathogenic Escherichia coli effector protein NleE. J. Immunol. 185:4118-4127.
96. Wickham ME, et al. 2006. Bacterial genetic determinants of non-O157 STEC outbreaks and hemolytic-uremic syndrome after infection. J. Infect. Dis. 194:819-827.
97. Wickham ME, et al. 2007. Citrobacter rodentium virulence in mice associates with bacterial load and the type III effector NleE. Microbes Infect. 9:400-407.
98. Wu B, et al. 2010. NleG Type 3 effectors from enterohaemorrhagic Escherichia coli are U-Box E3 ubiquitin ligases. PLoS Pathog. 6:e1000960. doi:10.1371/journal.ppat.1000960.
99. Yang J, Tauschek M, Hart E, Hartland EL, Robins-Browne RM. 2010. Virulence regulation in Citrobacter rodentium: the art of timing. Microb. Biotechnol. 3:259-268.
100. Zurawski DV, et al. 2008. The NleE/OspZ family of effector proteins is required for polymorphonuclear transepithelial migration, a characteristic shared by enteropathogenic Escherichia coli and Shigella flexneri infections. Infect. Immun. 76:369-379.